Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study
Status:
Recruiting
Trial end date:
2026-10-01
Target enrollment:
Participant gender:
Summary
This study is looking at outcomes in people with advanced cancers who have exhausted standard
treatment options and are accessing off indication or unregistered drugs or combinations of
drugs through compassionate access from the manufacturer.